T cell repopulation from functionally restricted splenic progenitors: 10,000-fold expansion documented by using limiting dilution analyses - PubMed (original) (raw)

Comparative Study

. 1984 Dec;133(6):2925-32.

• PMID: 6238091

Comparative Study

T cell repopulation from functionally restricted splenic progenitors: 10,000-fold expansion documented by using limiting dilution analyses

R A Miller et al. J Immunol. 1984 Dec.

Abstract

Mice depleted of T cells by thymectomy, lethal irradiation, and reconstitution with Thy-1-depleted syngeneic bone marrow were given graded doses of splenic T cells to see whether post-thymic cells had the ability to regenerate immune function in these hosts. Using limiting dilution methods to estimate the number of antigen- and mitogen-responsive cells in recipients 12 to 20 wk after reconstitution, we found that new helper and cytotoxic precursor cells were produced, but attained levels only 10 to 20% of normal. Because these repopulated mice were able to produce nearly normal levels of helper and cytotoxic activity in conventional, high density cultures, despite their relative paucity of precursors, we infer that their normal function in conventional assays may reflect a balanced deficiency of effector and regulatory cell types. Surface phenotyping of the progenitor cells responsible for repopulation showed that Lyt-2- cells were required for helper cell regeneration and that Lyt-2+ cells acted as progenitors only for the cytotoxic lineage, contrary to earlier speculation that the splenic Lyt-1+ 2+ (Ly-123) pool included cells antecedent to both effector lineages. Comparison of the number of injected progenitors needed to produce repopulation with the number of new precursor cells eventually produced suggests that the relevant progenitors are able to undergo 10,000-fold expansion in 12 to 20 wk. Numerical expansion in the periphery from thymic-processed cells could well be a major source of new lymphocytes in adult mice.

PubMed Disclaimer

Similar articles

• Cytotoxic T lymphocytes, interleukin-2 and trophoblast involvement.
  Toder V, Blank M, Nebel L. Toder V, et al. Contrib Gynecol Obstet. 1985;14:23-35. Contrib Gynecol Obstet. 1985. PMID: 2415297 Review. No abstract available.
• Murine T cell subsets and interleukins: relationships between cytotoxic T cells, helper T cells and accessory cells.
  Wagner H, Kronke M, Solbach W, Scheurich P, Röllinghoff M, Pfizenmaier K. Wagner H, et al. Clin Haematol. 1982 Oct;11(3):607-30. Clin Haematol. 1982. PMID: 6217007 Review. No abstract available.

Cited by

• The effects of chronic infection with a superantigen-producing virus.
  Ignatowicz L, Kappler J, Marrack P. Ignatowicz L, et al. J Exp Med. 1992 Apr 1;175(4):917-23. doi: 10.1084/jem.175.4.917. J Exp Med. 1992. PMID: 1348082 Free PMC article.
• Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood.
  Tary-Lehmann M, Saxon A. Tary-Lehmann M, et al. J Exp Med. 1992 Feb 1;175(2):503-16. doi: 10.1084/jem.175.2.503. J Exp Med. 1992. PMID: 1346272 Free PMC article.
• Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor gamma delta.
  Bandeira A, Itohara S, Bonneville M, Burlen-Defranoux O, Mota-Santos T, Coutinho A, Tonegawa S. Bandeira A, et al. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):43-7. doi: 10.1073/pnas.88.1.43. Proc Natl Acad Sci U S A. 1991. PMID: 1986381 Free PMC article.
• Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?
  Zöller M. Zöller M. Cancer Immunol Immunother. 2004 Aug;53(8):659-76. doi: 10.1007/s00262-004-0503-2. Epub 2004 Apr 6. Cancer Immunol Immunother. 2004. PMID: 15067430 Free PMC article. Review.
• Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo.
  Nijhuis EW, Remarque EJ, Hinloopen B, Van der Pouw-Kraan T, Van Lier RA, Ligthart GJ, Nagelkerken L. Nijhuis EW, et al. Clin Exp Immunol. 1994 Jun;96(3):528-34. doi: 10.1111/j.1365-2249.1994.tb06061.x. Clin Exp Immunol. 1994. PMID: 7911751 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information